期刊文献+

基蛋Getein 1600干式免疫荧光法检测降钙素原的性能验证

Performance verification of Getein1600 dry immunofluorescence quantitative analyzer in determination of procalcitonin
下载PDF
导出
摘要 目的对基蛋Getein 1600干式免疫荧光法检测降钙素原(PCT)进行性能验证,以确保检测结果的准确性和可靠性,为临床提供质量保证。方法参考国家相关卫生行业标准(WS/T 420-2013),通过收集2019年8月广州中医药大学第二附属医院检验科34例无脂血、无黄疸、无溶血的肝素锂抗凝标本并设计试验,采用基蛋Getein 1600干式免疫荧光法检测PCT的精密度、正确度、线性范围,并进行性能验证。结果重复标准差Sr为0.01、0.59,期间标准差Sl为0.01、0.57;与比较方法相对偏移¯brel为19.01;在0.10~36.81μg/L内,R2=0.9979。均在说明书范围内。结论基蛋Getein 1600干式免疫荧光法检测PCT的主要分析性能良好,可用于临床标本的检测。 Objective To verify the performance of Getein1600 dry immunofluorescence quantitative analyzer in the determination of procalcitonin(PCT),to ensure the accuracy and reliability of the PCT assay results,and to provide quality assurance for clinical practice.Methods The precision,accuracy,and linear range of PCT assay via Getein1600 dry immunofluorescence quantitative analyzer were verified based on the requirements of the relevant Chinese industry guidelines(WS/T 420-2013)by collecting specimens from Clinical Laboratory,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine in August 2019 and designing the test.Results The reproducibility standard deviations(Sr)were 0.01 and 0.59;the intermediate precisions(Sl)were 0.01 and 0.57;the relative bias(¯brel)between the investigated method and the reference method was 19.01;the linearity was established within the range of 0.10-36.81μg/L,with a R2 of 0.9979.All the verification results were within the range in the Instructions for Use.Conclusion Getein1600 dry immunofluorescence quantitative analyzer shows a good performance in PCT assay,and is suitable for the measurement of clinical samples.
作者 余锦旗 何伟 林倩倩 陈颖婷 欧财文 宋丽婷 Yu Jinqi;He Wei;Lin Qianqian;Chen Yingting;Ou Caiwen;Song Liting(Clinical Laboratory,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Dermatology,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Emergency Room,Tongde Branch,The Affiliated Hospital of Traditional Chinese Medicine,Guangzhou Medical University,Guangzhou 510130,China)
出处 《国际医药卫生导报》 2022年第15期2098-2100,共3页 International Medicine and Health Guidance News
基金 广东省中医药局湿症专项(20225029)。
关键词 降钙素原 性能验证 干式免疫荧光法 Procalcitonin Performance verification Dry immunofluorescence
  • 相关文献

参考文献7

二级参考文献155

  • 1Whang KT, Vath SD, Becker KL, et al. Procalcitonin and pro-inflammatory cytokine interactions in sepsis [ J]. Shock,2000,14(1): 73-78.
  • 2Nijsten MW, Olinga P, The TH,et al. Procalcitonin behaves as a fastresponding acute phase protein in vivo and in vitro [ J]. Crit Care Med, 2000, 28 (2): 458461.
  • 3Wiedermann FJ,Kaneider N,Egger P, et al. Migration of human monocytes in response to procalcitonin [J]. Crit Care Med, 2002 , 30(5): 1112-1117.
  • 4Hoffmann G, Totzke G, Seibel M, et al. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin [J]. Crit Care Med, 2001, 29 (1): 112-126.
  • 5Morgenthaler NG, Struck J, Chancerelle Y,et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection [J]. Horm Metab Res, 2003 , 35 ( 5): 290-295.
  • 6Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin- influence of temperature,storage,anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations [J]. EurJ Clin Chem Clin Biochem, 1997 , 35 ( 8): 597-601.
  • 7Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia [J]. Ann Emerg Med, 2008 , 52 (1): 48-58.
  • 8Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes [J]. Eur Respir J,2008,31 (2): 349-355.
  • 9Hirakata Y,Yanagihara K, Kurihara S, et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia [J]. Diagn Microbiol Infect Dis, 2008 , 61 (2): 170-174.
  • 10Chan YL, Tseng CP, Tsay PK, et al. Procalcitonin as a marker of bacterial infection in the emergency department : an observational study[J]. Crit Care, 2(XM, 8 (1): R12-20.

共引文献693

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部